1/3
08:51 am
avdl
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8 [Yahoo! Finance]
Low
Report
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8 [Yahoo! Finance]
1/3
08:00 am
avdl
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8
Low
Report
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8
12/12
05:22 am
avdl
Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock [Yahoo! Finance]
Low
Report
Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock [Yahoo! Finance]
12/11
08:08 am
avdl
Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy [Yahoo! Finance]
Medium
Report
Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy [Yahoo! Finance]
12/11
08:00 am
avdl
Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy
Medium
Report
Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy
11/27
06:47 am
avdl
Narcolepsy Treatment Market 2024 to 2034 Projected to Reach USD 8,718.3 Million by 2034 with 5.1% CAGR | Future Market Insights, Inc. [Yahoo! Finance]
Low
Report
Narcolepsy Treatment Market 2024 to 2034 Projected to Reach USD 8,718.3 Million by 2034 with 5.1% CAGR | Future Market Insights, Inc. [Yahoo! Finance]
11/26
10:15 am
avdl
Sleep Consortium Announces the Illuminate Hypersomnia Adjunct Scientific Meeting to Tackle Drug Development Challenges for Idiopathic Hypersomnia [Yahoo! Finance]
Low
Report
Sleep Consortium Announces the Illuminate Hypersomnia Adjunct Scientific Meeting to Tackle Drug Development Challenges for Idiopathic Hypersomnia [Yahoo! Finance]
11/18
12:33 pm
avdl
State-of-the-science webinar will explore narcolepsy and hypersomnia
Low
Report
State-of-the-science webinar will explore narcolepsy and hypersomnia
11/13
08:28 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at HC Wainwright from $27.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at HC Wainwright from $27.00 to $25.00. They now have a "buy" rating on the stock.
11/13
08:00 am
avdl
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Medium
Report
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
11/13
02:26 am
avdl
Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ... [Yahoo! Finance]
High
Report
Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ... [Yahoo! Finance]
11/12
03:20 pm
avdl
Avadel Pharmaceuticals plc (AVDL) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Low
Report
Avadel Pharmaceuticals plc (AVDL) Q3 2024 Earnings Call Transcript [Seeking Alpha]
11/12
08:33 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
High
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
11/12
07:00 am
avdl
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results
High
Report
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results
11/11
07:33 am
avdl
Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Low
Report
Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
11/4
08:00 am
avdl
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12
Low
Report
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12
11/1
08:40 am
avdl
Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
Low
Report
Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
10/31
04:35 pm
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
10/31
02:35 pm
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Oppenheimer Holdings Inc. from $29.00 to $30.00. They now have an "outperform" rating on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Oppenheimer Holdings Inc. from $29.00 to $30.00. They now have an "outperform" rating on the stock.
10/31
08:35 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Medium
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
10/31
07:00 am
avdl
Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation
Medium
Report
Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation
10/24
08:00 am
avdl
Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances
Neutral
Report
Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances
10/21
08:07 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Medium
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
10/18
08:33 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Medium
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
10/17
09:41 am
avdl
Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy
Medium
Report
Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy